Erectile Dysfunction

"DermaSys is a versatile and bespoke technology in that it can be tailored to suit the specific active compound being used and the therapeutic indication," said Futura.

"Such targeted delivery offers an optimised profile in terms of dose, onset time and duration of effect as well as an improved safety profile through lower systemic uptake and the reduced risk of side effects."The technology takes the form of a gel that incorporates volatile solvents which evaporate on contact with the skin.

As the gel dries, the concentration of the active rises until it becomes 'supersaturated', driving the drug across the skin.

Studies indicate that DermaSys can deliver active into target tissues within three minutes.Moreover, very little of the drug enters the blood, so systemic exposure is limited, according to Futura.The UK company is perhaps best known for its condom product based on glyceryl trinitrate, a vasodilator drug, designed to help men maintain a full erection during intercourse and prevent the condom slipping off.

E-mail this page to a colleague Print in friendly format Related product presentations ...

Read more...